| DIRECT COMPETITOR COMPARISON | |
| NEXM | ADMP.OB | NOVN | PFE | Industry | | Market Cap: | 23.07M | 10.53M | N/A | 147.12B | 161.24M | | Employees: | 13 | N/A | N/A | 81,800 | 103 | | Qtrly Rev Growth (yoy): | -64.20% | -2.40% | N/A | -2.90% | 20.50% | | Revenue (ttm): | 6.18M | 656.87K | N/A | 45.82B | 46.74M | | Gross Margin (ttm): | 53.09% | 59.44% | N/A | 86.61% | 68.58% | | EBITDA (ttm): | 171.50K | -4.61M | N/A | 21.31B | -7.12M | | Oper Margins (ttm): | -3.75% | -705.27% | N/A | 37.42% | 2.25% | | Net Income (ttm): | -792.20K | -4.89M | N/A | 8.09B | N/A | | EPS (ttm): | -0.009 | 0.038 | N/A | 1.204 | -0.17 | | P/E (ttm): | N/A | 7.11 | N/A | 15.14 | 17.12 | | PEG (5 yr expected): | N/A | N/A | N/A | 5.88 | 1.04 | | P/S (ttm): | 3.25 | 16.03 | N/A | 3.21 | 4.17 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.34 | -0.28% | 57.02B | 12.29 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.05 | 0.28% | 13.61B | 15.75 | | Genzyme Corp. | GENZ | 50.7406 | -0.64% | 13.47B | 28.93 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.0701 | -1.05% | 41.46B | 17.82 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.57 | -0.76% | 8.84B | 1011.63 | | Teva Pharmaceutical Industries Limited | TEVA | 52.54 | -0.64% | 46.29B | 48.07 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.17 | 0.57% | 3.95B | 19.16 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.82 | -1.09% | 2.93B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.83 | -1.00% | 5.45B | 109.39 | | Pfizer Inc. | PFE | 18.231 | -0.10% | 147.12B | 15.14 | | Johnson & Johnson | JNJ | 62.7499 | -0.22% | 173.13B | 13.70 | | GlaxoSmithKline plc | GSK | 41.26 | -2.37% | 104.59B | 13.10 | | Sanofi-Aventis | SNY | 37.82 | -1.59% | 98.75B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.4001 | 0.04% | 125.82B | 16.59 | | RHHBY.PK | 40.85 | -1.47% | N/A | N/A | | AstraZeneca plc | AZN | 44.62 | -1.48% | 64.70B | 8.96 | | Abbott Laboratories | ABT | 54.305 | 0.42% | 84.00B | 14.71 | | Bristol-Myers Squibb Co. | BMY | 25.33 | -0.20% | 50.18B | 13.10 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | PFE | | The FDA Moves the Goalposts
Mon 2:14pm -
at Motley Fool | | • | PFE | | Could Cadiz Quench So Cal's Thirst?
Mon 1:41pm -
at SmartMoney.com | | • | PFE | | Experienced Small Cap Portfolio Manager Priced Fair Market Value For IMS Health At $17 To $18 Per Share
Mon 1:16pm -
Wall Street Transcript | | • | PFE | | The Real Problem With the Public Health-Care Plan
Mon 12:49pm -
at Motley Fool | | • | PFE | | Drugs: Cost is the highest barrier for treatments
Mon 12:20pm -
at FT.com | | • | ADMP.OB | | ADAMIS PHARMACEUTICALS CORP Financials
Sat, Nov 28 -
EDGAR Online Financials | | • | ADMP.OB | | Beacon Equity Issues Technical Trading Overview for NexMed Inc.
Wed, Nov 25 -
GlobeNewswire | | • | ADMP.OB | | ADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
Tue, Nov 24 -
EDGAR Online | | • | ADMP.OB | | Adamis Pharmaceuticals Secures Contracts and Ships Orders to the Three Largest Drug Wholesalers
Wed, Nov 11 -
Business Wire | | • | ADMP.OB | | Walgreens Pharmacies to Offer Adamis' Pre-Filled Epinephrine Syringe as Generic Option for Customers
Wed, Sep 16 -
Business Wire | | • | NOVN | | NOVEN PHARMACEUTICALS INC Files SEC form 8-K, Changes in Control or Registrant
Mon, Aug 24 -
EDGAR Online | | • | NOVN | | NOVEN PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
Thu, Aug 6 -
EDGAR Online | | • | NOVN | | 3 Stocks Hitting High Notes
Fri, Jul 24 -
at Motley Fool | | • | NOVN | | 4-Star Stocks on the Upswing
Thu, Jul 23 -
at Motley Fool | | • | NOVN | | Kendall Law Group Announces Lawsuit on Behalf of Noven Shareholders
Wed, Jul 22 -
Marketwire | | | All Headlines for these symbols... |
|
|
|
0.12% Nasdaq 
0.0311 (14.74%) 
Competitors
